Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

ABSTRACT The novel coronavirus, SARS-coronavirus (CoV)-2 (SARS-CoV-2), has caused over 17 million infections in just a few months, with disease manifestations ranging from largely asymptomatic infection to critically severe disease. The remarkable spread and unpredictable disease outcomes continue t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carolin Loos, Caroline Atyeo, Stephanie Fischinger, John Burke, Matthew D. Slein, Hendrik Streeck, Douglas Lauffenburger, Edward T. Ryan, Richelle C. Charles, Galit Alter
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Fc-receptor binding
SARS-CoV-2
antibody response
cross-reactivity
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/d055acc5916d4b90b38ae24bc3bbd195
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares